Sec. 2. Modernizing the authentication of controlled substances in the pharmaceutical distribution supply chain
303 words·~1 min read·
/bill/118/hr/4988/ih/section-2A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Section 582(a)(9) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360eee–1(a)(9) ) is amended— in subparagraph (A)(ii), by striking and at the end; by redesignating subparagraph
(B)as subparagraph (C); and by inserting after subparagraph
(A)the following: a physical chemical identifier shall be included in or on each dose of a product that is— a controlled substance (as defined in section 102 of the Controlled Substances Act); in solid oral dosage form; and manufactured on or after the date that is five years after the date of enactment of the Modern Authentication of Pharmaceuticals Act of 2023 ; and . Section 581(14) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360eee(14) ) is amended to read as follows: The term product identifier means— a standardized graphic that includes, in both human-readable form and on a machine-readable data carrier that conforms to the standards developed by a widely recognized international standards development organization, the standardized numerical identifier, lot number, and expiration date of the product; or a physical chemical identifier, possessing a unique physical or chemical substance or combination of substances, that— is in or on a product; is machine readable; and is intended to authenticate the product or a dosage form thereof. . Section 581(28) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360eee(28) ) is amended to read as follows: The term verification or verify means— determining whether the product identifier affixed to, or imprinted upon, a package or homogeneous case corresponds to the standardized numerical identifier or lot number and expiration date assigned to the product by the manufacturer or the repackager, as applicable in accordance with section 582; or determining whether a product or a dosage form thereof is authentic using a physical chemical identifier described in paragraph (14)(B). .
Connectionstraces to 1
Traces to 1 document
U.S. Code
1 reference not yet in our index
- 21 USC 360eee–1(a)(9)
Citation graph
cites case law
Sec. 2
Modernizing the authentication of controlled substances in the pharmaceutical distribution supply chain
Cite21 USC 360eee–1(a)(9)
Cites 2Cited by 0 across 0 sources